News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Agreement Combines System And Know-How - Leica Microsystems And Axaron Bioscience AG Extend Cooperation With Co-Marketing Agreement

10/19/2005 5:10:28 PM

Heidelberg, Germany, November 13, 2003 - Leica Microsystems and the Heidelberg biotechnology company Axaron Bioscience AG signed an agreement on November 12th, 2003, to co-market their laser microdissection products and services for gene expression analysis. This agreement covers Leica's AS LMD Laser Microdissection System and Axaminer, Axaron's comprehensive service for cell type-specific transcription profiling. The co-marketing is an extension of the already existing cooperation between the two companies.

Leica and Axaron expect their joint marketing activities to attract new customers who will benefit from the advantages of the cooperation: with the services offered for cell-specific gene expression analysis and the automation of this process, the partners will optimize the R&D projects of their customers in joint workshops and seminars with users.

Since the market launch of the Leica AS LMD, Leica Microsystems has continued to develop its precise and gentle method of selective cell separation for new applications. The company's aim is to improve the accuracy and throughput of cell isolation in scientific research - especially in molecular pathology. Axaminer's role in this cooperation is to enable the labeling of specific cells and the subsequent gene expression analysis of isolated cells. The combination of Leica's automated laser dissection and Axaron's know-how in the field of cell type-specific transcription profiling results in a unique service for drug discovery and development.

"Since 2002, we have been working successfully with Axaron on software that automatically recognizes and dissects labelled cells in histological tissue, "explains Leica's Marketing Manager, Werner Kampe. "It is our common goal to develop an automated laser microdissection system for cell recognition which will complement Axaron's wide knowledge of sample preparation and gene expression analysis to significantly improve analysis results in the future drug discovery. " (278 words)

Media Contact:
Gisela Blaas
Axaron Bioscience AG
Im Neuenheimer Feld 515
69120 Heidelberg
Tel.: 06221 454-705
Fax: 06221 454-776

Axaron Bioscience AG is a Heidelberg-based biotechnology company which pioneers innovative therapies for neurodegenerative diseases such as stroke or Parkinson's. The company capitalizes on its uniquely integrated functional genomics and proteomics technology platform and its world-leading network of expert partners in the CNS field. Axaminer is based on Axaron's proprietary technology and enables gene expression profiling at a cellular level. The Axaminer technology comprises four integrated modules offered as a full service or tailor-made solution to pharmaceutical companies. For further information please visit Leica Microsystems is a leading global designer and producer of innovative high-tech precision optics systems for the analysis of microstructures. It is one of the market leaders in each of its five business areas Microscopy, Imaging Systems, Specimen Preparation, Medical Equipment and Semiconductor Equipment. The company manufactures a broad range of products for numerous applications, which require either microscopic visual presentation, measurement, analysis or electron-beam lithography. The company offers system solutions in the areas of Life Science including biotechnology and medicine, as well as the science of raw materials, industrial quality assurance and the semiconductor industry. The company is represented in over 100 countries with 11 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. With its workforce of about 3750 employees it makes a turnover of 604m Euros. The international management is headquartered in Wetzlar, Germany.

Read at

comments powered by Disqus